Hospital
Southern Hills Medical Center, LLC
Southern Hills Medical Center, LLC was paid $2.64M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoSOUTHERN HILLS MEDICAL CENTER, LLC
LAS VEGAS, NV 89148
LAS VEGAS, NV 89148
33aNPI1881631950assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.64M
24GClaims214,305
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Nevada
Rank by total paid#23 of 36
Median peer was paid$7.64M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,074 | $320K | |
| 2019 | 34,943 | $399K | |
| 2020 | 36,616 | $384K | |
| 2021 | 38,583 | $423K | |
| 2022 | 32,176 | $476K | |
| 2023 | 29,761 | $399K | |
| 2024incomplete | 11,152 | $237K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 11,047 | 9,045 | $783K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 4,918 | 3,688 | $475K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 9,909 | 8,506 | $447K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 16% | 1,892 | 1,598 | $429K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.3% | 2,145 | 1,776 | $165K |
| G0378 | Hospital observation service, per hour | 4.5% | 4,534 | 3,154 | $118K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.2% | 346 | 281 | $57K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.9% | 262 | 221 | $51K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 1,319 | 1,222 | $35K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 4,191 | 2,876 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 657 | 589 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,046 | 5,465 | $6K |
93 more codes
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 18 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 134 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,147 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,635 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,081 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 178 | $2K |
| 96376 | <1% | 1,837 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,892 | $2K |
| 85027 | <1% | 17,068 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,122 | $1K |
| 84703 | <1% | 3,238 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,393 | $1K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,598 | $986.04 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,423 | $765.37 |
| 80076 | <1% | 3,521 | $740.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,394 | $560.75 |
| 84484 | <1% | 5,154 | $554.13 | |
| 80053 | Comprehensive metabolic panel | <1% | 9,619 | $495.55 |
| 83880 | <1% | 1,777 | $403.99 | |
| 83690 | <1% | 4,792 | $391.33 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 838 | $373.47 |
| 81025 | <1% | 1,352 | $338.55 | |
| 93975 | <1% | 52 | $321.75 | |
| 80047 | <1% | 2,722 | $318.13 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 87 | $307.86 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 610 | $302.05 |
| 82550 | <1% | 3,181 | $271.69 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 965 | $256.55 |
| 81001 | <1% | 5,096 | $255.84 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,446 | $242.27 |
| 87040 | <1% | 2,365 | $238.02 | |
| 85730 | <1% | 3,284 | $208.27 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 33 | $203.54 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 444 | $193.10 |
| 85610 | <1% | 4,945 | $174.21 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,696 | $157.95 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 299 | $155.42 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 44 | $135.39 |
| 84702 | <1% | 146 | $121.95 | |
| 83735 | <1% | 2,595 | $114.23 | |
| 93971 | <1% | 40 | $102.14 | |
| 87088 | <1% | 611 | $77.42 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 355 | $75.90 |
| 83605 | <1% | 937 | $72.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,715 | $51.29 |
| 87430 | <1% | 184 | $49.08 | |
| 81003 | <1% | 1,496 | $39.73 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,348 | $36.83 |
| 86901 | <1% | 943 | $36.60 | |
| 86900 | <1% | 943 | $36.60 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,958 | $33.34 |
| J3490 | Unclassified drugs | <1% | 241 | $29.62 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,942 | $27.06 |
| 84100 | <1% | 966 | $25.84 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 43 | $23.94 |
| 87077 | <1% | 132 | $22.08 | |
| 85379 | <1% | 25 | $20.85 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 397 | $17.93 |
| 87186 | <1% | 24 | $11.80 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 336 | $10.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 751 | $10.06 |
| 86850 | <1% | 272 | $9.35 | |
| 82077 | <1% | 1,548 | $8.63 | |
| 82248 | <1% | 1,724 | $6.84 | |
| J1815 | Injection, insulin, per 5 units | <1% | 95 | $2.61 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 21 | $2.56 |
| J2704 | Injection, propofol, 10 mg | <1% | 321 | $2.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 452 | $0.91 |
| A9270 | Non-covered item or service | 0% | 8,600 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 208 | $0.00 |
| 82553 | 0% | 461 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 947 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 152 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 172 | $0.00 |
| 87070 | 0% | 113 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 19 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 67 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 18 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 22 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 14 | $0.00 |
| 86920 | 0% | 14 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 14 | $0.00 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 13 | $0.00 |
| 93017 | 0% | 18 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 20 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 16 | $0.00 |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 0% | 14 | $0.00 |
| 72100 | 0% | 12 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 18 | $0.00 |
| 87210 | 0% | 16 | $0.00 | |
| 87420 | 0% | 14 | $0.00 | |
| 73110 | 0% | 16 | $0.00 | |
| 73630 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLE, JENNIFER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Southern Hills Medical Center, LLC | Las Vegas, NV | $1.16M |
| Southern Hills Medical Center, LLC | Las Vegas, NV | $661K |
| Southern Hills Medical Center, LLC | Las Vegas, NV | $109K |
| DRS. Bui & Le Optometry Professional Corporation | San Jose, CA | $79K |
| Southern Hills Medical Center, LLC | Las Vegas, NV | $46K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.